MALAT1 and cancer: Given the inhibitory effect of hsa-miR-429 on EMT, we speculate that HIF-1 tumor-specific impact on lncRNAs levels, e.g., MALAT1 or XIST, could potentially help cancer cells to overcome the hsa-miR-429-related blockaid and shift the cells towards EMT.